Kovitz Investment Group Partners LLC Takes Position in Tempus AI, Inc. (NASDAQ:TEM)

Kovitz Investment Group Partners LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 24,186 shares of the company's stock, valued at approximately $1,367,000.

Several other large investors have also recently bought and sold shares of the stock. Stifel Financial Corp acquired a new stake in Tempus AI during the third quarter worth about $218,000. Benjamin Edwards Inc. bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $725,000. NEA Management Company LLC grew its holdings in shares of Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock worth $304,846,000 after purchasing an additional 813,169 shares in the last quarter. Captrust Financial Advisors bought a new stake in shares of Tempus AI during the third quarter valued at approximately $2,726,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Tempus AI by 10.2% in the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company's stock valued at $1,686,000 after purchasing an additional 2,765 shares in the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Guggenheim initiated coverage on shares of Tempus AI in a research note on Monday. They set a "buy" rating and a $74.00 price target on the stock. Stifel Nicolaus lowered shares of Tempus AI from a "buy" rating to a "hold" rating and lifted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler reissued a "neutral" rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Bank of America cut shares of Tempus AI from a "buy" rating to a "neutral" rating and raised their price target for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Finally, Loop Capital upped their price objective on Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research note on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $56.20.

Tempus AI Stock Performance

Shares of NASDAQ:TEM traded down $1.81 during trading on Wednesday, reaching $43.19. The stock had a trading volume of 11,439,769 shares, compared to its average volume of 1,326,075. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $79.49. The firm has a 50-day simple moving average of $53.18.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.